18.01.2018
- GlaxoSmithKline (GSK), the UK’s largest drugmaker in terms of sales, is rumored to be preparing a bid for compatriot Vectura, an inhaled airways disease-focused player. The two...
03.10.2017
- Major French industrial gases group Air Liquide has expanded its healthcare business in Japan with the acquisition of Sogo Sangyo Kabushiki Kaisha (SSKK). Financial terms were not...
17.05.2017
- AstraZeneca is to collaborate with US-based Pieris Pharmaceuticals to develop novel inhaled drugs for respiratory diseases. The deal will leverage Pieris’ Anticalin platform and...
05.12.2016
- Anglo-Swedish drugmaker AstraZeneca is collaborating with Bicycle Therapeutics to develop a novel class of small-molecule medicines for treating respiratory, cardiovascular and...
07.04.2015
- Belgium's UCB has agreed to sell its established brands in India, including its franchises in the areas of allergies and respiratory disorders, to Dr. Reddy's Laboratories for INR...
